Medicine for retarding breast cancer cell division and preparation method thereof
A breast cancer cell and drug technology, applied in the field of drugs for slowing the division of breast cancer cells and its preparation, and the field of drugs for slowing the division of cancer cells, can solve the problems of slow curative effect and insufficient inhibitory effect, and achieve significant curative effect and inhibit breast cancer. Cell proliferation, no toxic side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Preparation of a drug for slowing down breast cancer cell division.
[0026] A medicine for slowing down the division of breast cancer cells. Its raw material components include 10.2 parts of silver thread grass, 2.2 parts of onion, 21.2 parts of poplar buds or bud scales, 6.3 parts of Sperantosporum, and 17.6 parts of mimosa.
[0027] Weigh each component according to the above parts by mass, and pretreat each component to obtain its extract or modified extract. The specific preparation method of each component extract or modified extract is as follows:
[0028] Preparation of Silvertracea extract: Extract Silvertracea with reflux of 95% ethanol, recycle ethanol to obtain its ethanol extract, then degrease the extract with petroleum ether and perform AB-8 macroporous resin column chromatography, and then use Silverwort extract was obtained by elution with 50% ethanol.
[0029] Preparation of onion extract: wash the onion and put it into a pulverizer to crush it, boil ...
Embodiment 2
[0038] Effect of the pharmaceutical composition of the present invention on transplanted breast cancer.
[0039] (1) Preparation of transplanted breast cancer mouse model
[0040] 36 SPF female healthy TA2 mice, 6 weeks old, body weight 16g-18g. Take the MA-891 mouse breast cancer cells in logarithmic growth phase cultured in vitro, and adjust the concentration of MA-891 cells with sterile PBS to 1×10 7 / mL. Under sterile conditions, MA-891 mouse breast cancer cells were inoculated subcutaneously in the right axilla of TA2 mice, with an inoculation volume of 0.2ml / mouse (the number of cells was 2×10 6 / only). The entire inoculation process must be carried out in a sterile hood with aseptic operation, and the inoculation should be completed within 1 hour. The volume of the subcutaneous transplanted tumor reaches 60mm 3 Around time (about l0d), the model is successfully manufactured.
[0041] (2) Grouping and administration
[0042] According to the principle of tumor vol...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com